US 10953000
Combination of pimavanserin and cytochrome P450 modulators
granted A61KA61K31/4468A61K31/496
Quick answer
US patent 10953000 (Combination of pimavanserin and cytochrome P450 modulators) held by ACADIA Pharmaceuticals Inc. expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4468, A61K31/496, A61K45/06, A61K9/0053